Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edesa Biotech Inc (NQ: EDSA )

0.6320 -0.0850 (-11.85%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 144,648
Open 0.7000
Bid (Size) 0.6200 (35)
Ask (Size) 0.7598 (10)
Prev. Close 0.7170
Today's Range 0.6200 - 0.7230
52wk Range 0.5100 - 2.810
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... 
Via Benzinga
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
Via ACCESSWIRE

Performance

YTD
-68.40%
-68.40%
1 Month
-24.49%
-24.49%
3 Month
-24.31%
-24.31%
6 Month
-36.65%
-36.65%
1 Year
-42.55%
-42.55%

More News

Read More
Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors
Via Benzinga
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studies
Via Benzinga
Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens
Via ACCESSWIRE
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Swiss Biotech Day
Via ACCESSWIRE
The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate
Via ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference
Via ACCESSWIRE
Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
Via ACCESSWIRE
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
Via ACCESSWIRE
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
Via ACCESSWIRE
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
Via Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Via Benzinga
Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
Via Benzinga
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
Via ACCESSWIRE
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.